The Global Facial Injectable Market size is expected to reach $22.5 billion by 2029, rising at a market growth of 10.1% CAGR during the forecast period.
Facial Line Correction constitutes the largest part of the market as the ageing population continues to increase, and as a result, there is a huge demand for surgeries and treatments that can make people look younger. Hence, generated $3,998 million revenue in 2022. Around 727 million individuals are 65 years of age or older, globally, according to the United Nations Department of Economic and Social Affairs. Additionally, there are increasingly more people in their 50s and older. Some of the factors impacting the market are growing popularity of facial injectables among men, growing demand for aesthetic procedures, and possible side effects of facial injectables.
The fact that more men are anticipated to use facial-type injectables in the next years is one of the most distinctive and pervasive trends currently seen in the market. During the forecast period, it is anticipated that this specific trend will favorably impact market expansion. During the forecast period, the male population is anticipated to embrace a variety of fillers, including dermal fillers and botulinum toxin. Aesthetic procedures are in greater demand nowadays due to several elements that have been developed, as well as increased awareness. Furthermore, there has been a significant rise in disposable income as economic progress occurs worldwide in developing nations. As a result, an increasing number of people are using various filler injections to enhance their aesthetic appearance.
However, Despite a significant and ongoing rise in demand for aesthetic operations like fillers and botulinum toxin, several obstacles limit market expansion. For instance, these procedures can have unpleasant side effects like pain, bruising, bumps, lumps, swelling at the injection site, infection, and redness. Additionally, if the facial injectable is injected into a blood vessel, it has occasionally resulted in rare but severe side effects, including eyesight loss, blurred vision, scarring, and blindness.
Cosmetic surgery offices and dermatology practices noticed a considerable rise in virtual consultations during the lockdown. As more regions abolish COVID-19 restrictions, this unmet demand is predicted to manifest in large numbers. In light of this, it can be stated that COVID-19 had a negative impact on the market initially but has been witnessing speedy recovery and significant growth since 2021.
Based on product, the market is segmented into collagen & PMMA microspheres, hyaluronic acid (HA), botulinum toxin type A, calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and others. The hyaluronic acid (HA) segment garnered a significant revenue share in the market in 2022. The ability of hyaluronic acid (HA) to keep moisture in the skin and give it a healthier appearance is widely established. Hyaluronic acid's moisture-binding ability helps increase and maintain the essential moisture that keeps the skin plump. Glycosaminoglycans such as hyaluronic acid (HA) support the maintenance of stable, protected, and continuously renewing skin. In the fluid around joints and the eyes, HA is more concentrated.
On the basis of application, the market is fragmented into facial line correction, lip augmentation, face lift, acne scar treatment, lipoatrophy treatment and others. In 2022, the facial line segment witnessed the largest revenue share in the market. This development is attributable to the rising popularity of facial injectables for cosmetic operations, including treating facial wrinkles, lip lines, and facial lines, to mention a few. The market is anticipated to rise due to rising disposable income and increased awareness of cosmetic procedures.
By end-use, the market is bifurcated into medSpa, dermatology clinics, and hospitals. In 2022, the medSpa segment held the highest revenue share in the market. A medspa is a place where cosmetic procedures are carried out under the guidance of a qualified doctor. These facilities offer non-invasive procedures like face injections, skin rejuvenation, non-invasive body contouring, and laser treatments, all carried out by qualified specialists. These establishments must adhere to all governmental regulations and requirements and must be owned by physicians.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 11.6 Billion |
| Market size forecast in 2029 | USD 22.5 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2029 |
| Revenue Growth Rate | CAGR of 10.1% from 2023 to 2029 |
| Number of Pages | 236 |
| Number of Table | 410 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Product, Application, End-use, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Taiwan, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region wise, the market is analysed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the market with the maximum revenue share. Over the projected period, the huge elderly populations in the U.S. and Canada are anticipated to fuel demand for facial injectables. The market's expansion is also fueled by the introduction of new products by major market players in North America. The population between the ages of 25 and 65 has grown, and this age group is more prone to skin disorders such as skin wrinkling.
Free Valuable Insights: Global Facial Injectable Market size to reach USD 22.5 Billion by 2029
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma Ltd., Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group), Anika Therapeutics, Inc., Prollenium Medical Technologies Inc., Galderma S.A., and Allergan PLC (AbbVie, Inc.).
By End-use
By Product
By Application
By Geography
The Market size is projected to reach USD 22.5 billion by 2029.
Growing popularity of facial injectables among men are driving the Market in coming years, however, Possible side effects of facial injectables restraints the growth of the Market.
Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma Ltd., Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group), Anika Therapeutics, Inc., Prollenium Medical Technologies Inc., Galderma S.A., and Allergan PLC (AbbVie, Inc.).
The Lip Augmentation market has shown the high growth rate of 9.8% during (2023 - 2029).
The Botulinum Toxin Type A market is leading the Market by Product in 2022 thereby, achieving a market value of $11.3 billion by 2029.
The North America market dominated the Market by Region in 2022 thereby, achieving a market value of $8.5 billion by 2029.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
